ABL and RD-Biotech sign strategic partnership in cell and gene therapy GMP manufacturing
Deal offers developers in cell and gene therapy streamlined access to plasmid DNA and viral vector manufacturing in new, flexible end-to-end serviceLyon and Besançon, France, October 25, 2022 – ABL, a pure play Contract Development and Manufacturing Organization (CDMO) with specialized expertise in the development a...
Philippe Dulieu Thierry Van Nieuwenhove Contract Research Organization Contract Development Manufacturing Organization Gene Therapy
Source: pharmiweb.com